235 related articles for article (PubMed ID: 8162873)
21. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
Schilling V; Bujia J; Negri B; Kastenbauer E
Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
[TBL] [Abstract][Full Text] [Related]
22. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.
Karmody CS; Northrop C
Otol Neurotol; 2012 Jan; 33(1):42-7. PubMed ID: 22143292
[TBL] [Abstract][Full Text] [Related]
23. Attic cholesteatoma and tympanosclerosis.
Deguine C; Pulec JL
Ear Nose Throat J; 1997 Jun; 76(6):364. PubMed ID: 9210800
[No Abstract] [Full Text] [Related]
24. [Epidermal Langerhans cells in cholesteatoma].
Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(3):150-1, 189. PubMed ID: 2702007
[TBL] [Abstract][Full Text] [Related]
25. The nature of the epithelium in acquired cholesteatoma.
Lee RJ; Mackenzie IC; Hall BK; Gantz BJ
Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):168-73. PubMed ID: 1712679
[TBL] [Abstract][Full Text] [Related]
26. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
Tinling SP; Chole RA
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
[TBL] [Abstract][Full Text] [Related]
27. [Reflections on cholesteatoma].
Aboulker P; Démaldent JE; Pelisse JM
Ann Otolaryngol Chir Cervicofac; 1975 Jun; 92(6):277-92. PubMed ID: 1217821
[TBL] [Abstract][Full Text] [Related]
28. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
[TBL] [Abstract][Full Text] [Related]
29. Gerbilline cholesteatoma development Part I: Epithelial migration pattern and rate on the gerbil tympanic membrane: comparisons with human and guinea pig.
Tinling SP; Chole RA
Otolaryngol Head Neck Surg; 2006 May; 134(5):788-93. PubMed ID: 16647536
[TBL] [Abstract][Full Text] [Related]
30. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
Schilling V; Bujía J; Holly A; Schulz P
Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
[TBL] [Abstract][Full Text] [Related]
31. Cholesteatoma or keratoma: A pathological approach.
Marquet J
Acta Otorhinolaryngol Belg; 1980; 34(1):5-11. PubMed ID: 7468193
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and surgical treatment of the middle ear cholesteatoma.
Rüedi L
Acta Otolaryngol Suppl; 1979; 361():1-45. PubMed ID: 286497
[No Abstract] [Full Text] [Related]
33. Expression of involucrin in human middle ear cholesteatoma.
Chao WY; Huang CC
Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
[TBL] [Abstract][Full Text] [Related]
34. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
Sasaki H; Huang CC
Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
[TBL] [Abstract][Full Text] [Related]
35. [Congenital cholesteatoma of the petrous process and mastoid: a report of two cases].
Pérez Obón J; Fernández Liesa R; Marín García J; Valero J; Eiras Ajuria J; Ortiz García A
Acta Otorrinolaringol Esp; 1995; 46(5):349-52. PubMed ID: 8554803
[TBL] [Abstract][Full Text] [Related]
36. The migration theory of cholesteatoma formation. Some experimental observations.
O'Donoghue GM
J Laryngol Otol; 1986 Apr; 100(4):395-8. PubMed ID: 3958584
[TBL] [Abstract][Full Text] [Related]
37. The postero-superior quadrant.
Dawes JD
J Laryngol Otol; 1974 Oct; 88(10):955-67. PubMed ID: 4470583
[No Abstract] [Full Text] [Related]
38. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
Holly A; Bujía J; Sanchez-Madrid F
Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
[TBL] [Abstract][Full Text] [Related]
39. [Case of middle ear cholesteatoma with integral tympanic membrane].
Zagaĭnova NS
Zh Ushn Nos Gorl Bolezn; 1977; (2):104-5. PubMed ID: 855447
[No Abstract] [Full Text] [Related]
40. Sialomucin in middle ear cholesteatoma perimatrix.
Nagai T; Kawano J; Suganuma T
Acta Otolaryngol; 1992; 112(4):686-90. PubMed ID: 1279931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
